This company has been marked as potentially delisted and may not be actively trading. Miragen Therapeutics (MGEN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock MGEN vs. OPGN, MASS, ALLO, VNDA, CERS, LFMD, NMRA, HITI, ALEC, and MREOShould you be buying Miragen Therapeutics stock or one of its competitors? The main competitors of Miragen Therapeutics include OpGen (OPGN), 908 Devices (MASS), Allogene Therapeutics (ALLO), Vanda Pharmaceuticals (VNDA), Cerus (CERS), LifeMD (LFMD), Neumora Therapeutics (NMRA), High Tide (HITI), Alector (ALEC), and Mereo BioPharma Group (MREO). These companies are all part of the "medical" sector. Miragen Therapeutics vs. Its Competitors OpGen 908 Devices Allogene Therapeutics Vanda Pharmaceuticals Cerus LifeMD Neumora Therapeutics High Tide Alector Mereo BioPharma Group OpGen (NASDAQ:OPGN) and Miragen Therapeutics (NASDAQ:MGEN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk. Does the media favor OPGN or MGEN? In the previous week, OpGen's average media sentiment score of 0.00 equaled Miragen Therapeutics'average media sentiment score. Company Overall Sentiment OpGen Neutral Miragen Therapeutics Neutral Do institutionals and insiders have more ownership in OPGN or MGEN? 2.7% of OpGen shares are held by institutional investors. 43.8% of OpGen shares are held by insiders. Comparatively, 1.1% of Miragen Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is OPGN or MGEN more profitable? OpGen has a net margin of -1,140.36% compared to Miragen Therapeutics' net margin of -1,393.50%. OpGen's return on equity of 0.00% beat Miragen Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets OpGen-1,140.36% N/A -287.58% Miragen Therapeutics -1,393.50%-141.66%-88.74% Which has more risk & volatility, OPGN or MGEN? OpGen has a beta of -1.77, indicating that its stock price is 277% less volatile than the S&P 500. Comparatively, Miragen Therapeutics has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Which has stronger valuation & earnings, OPGN or MGEN? OpGen has higher earnings, but lower revenue than Miragen Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOpGen$2.67M0.00-$32.67MN/AN/AMiragen Therapeutics$4.46M19.11-$41.87M-$20.09-1.09 SummaryOpGen beats Miragen Therapeutics on 5 of the 8 factors compared between the two stocks. Get Miragen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGEN vs. The Competition Export to ExcelMetricMiragen TherapeuticsMedical Laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$85.23M$1.23M$6.15B$10.64BDividend YieldN/AN/A5.66%4.69%P/E Ratio-2.05N/A85.9927.64Price / Sales19.111.83628.97141.97Price / CashN/AN/A38.3262.20Price / Book3.220.1112.956.79Net Income-$41.87M-$22.69M$3.30B$275.88M Miragen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGENMiragen TherapeuticsN/A$21.81+2.1%N/A-6.2%$85.23M$4.46M-2.0545High Trading VolumeOPGNOpGenN/AN/AN/AN/A$1K$2.67M0.00100MASS908 Devices1.8171 of 5 stars$9.15+2.7%$8.00-12.6%+159.6%$328.12M$59.63M-16.9460Analyst ForecastALLOAllogene Therapeutics2.6944 of 5 stars$1.47+8.9%$8.44+474.5%-42.8%$326.16M$20K-1.32310Analyst ForecastVNDAVanda Pharmaceuticals4.1081 of 5 stars$5.46+2.6%$16.50+202.2%+21.9%$322.63M$198.77M-4.83290Analyst ForecastCERSCerus2.2315 of 5 stars$1.68+5.0%$3.50+108.3%-10.7%$322.06M$180.27M-16.80290Positive NewsAnalyst ForecastLFMDLifeMD3.4821 of 5 stars$6.64+0.2%$13.17+98.3%+46.7%$314.87M$212.45M-31.62230Trending NewsAnalyst ForecastNMRANeumora Therapeutics2.314 of 5 stars$1.94+4.3%$7.14+268.2%-86.4%$314.18MN/A-1.24108Analyst ForecastHITIHigh Tide2.2743 of 5 stars$3.58-0.6%$6.13+71.1%+61.0%$311.86M$568.25M-44.751,550Analyst ForecastALECAlector3.6149 of 5 stars$3.08+0.3%$4.17+35.3%-36.4%$311.73M$100.56M-2.66270Analyst ForecastMREOMereo BioPharma Group2.1522 of 5 stars$1.96+0.5%$7.40+277.6%-49.3%$311.64M$10M-28.0040News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies OpGen Alternatives 908 Devices Alternatives Allogene Therapeutics Alternatives Vanda Pharmaceuticals Alternatives Cerus Alternatives LifeMD Alternatives Neumora Therapeutics Alternatives High Tide Alternatives Alector Alternatives Mereo BioPharma Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGEN) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Miragen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Miragen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
